StockData
Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Inc. (INBS) stock

INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3061% below fair value
$1.76−0.17 (-8.81%)

Close on Nov 13, 2026Market cap $5.33MP/E –Yield –

Intelligent Bio Solutions r&d expenses

Research and development expenses are spending on new products and technology.

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2021CQ4 2020Dec 31, 2020$341.82K–
Q2 FY2020CQ4 2019Dec 31, 2019$494.67K–

More Intelligent Bio Solutions figures

See a number that looks wrong?